(Reuters) — When the painkillers stop working, arthritic joint damage in the big toe can make even the weight of a bedsheet agonizing. Standard surgery eliminates that pain by removing the cartilage and fusing the bones, but at the expense of mobility. Cartiva Inc‘s implant – made of the same substance used in contact lenses, called […]
Cartiva said today that the FDA’s Orthopaedic and Rehabilitation Devices Panel voted in favor of the company’s synthetic cartilage implant for treating osteoarthritis at the base of the big toe. The panel voted 10 to 2 in favor of the safety of the implant and 9 to 3 in favor of the efficacy of the implant. […]
The FDA set dates with Cartiva and Angel Medical to review premarket approval applications for Cartiva’s Synthetic Cartilage Implant and Angel Medical’s Guardian cardiac monitor system, the companies said today. Alpharetta, Ga.-based Cartiva is slated to meet with the federal watchdog on April 20, to review the application for its SCI, which is designed to treat osteoarthritis […]
Synthetic implant company Cartiva closed a $4.3 million financing round led by venture capital firm New Enterprise Associates. As part of the round, 1 of the VC firm’s partners, Dr. Justin Klein, will join Cartiva’s board of directors.
The Alpharetta, Ga.-based device maker plans to use the funds to support trials for its synthetic cartilage implant for treatment of arthritis in the big toe. The implant is undergoing testing in a 236-patient study.